Congratulations to LCGC North America for 25 years of providing insightful resources to the scientific instrumentation community. As the leader in laboratory gas generation, Parker has relied upon LCGC as an important business partner in reaching our users. We see that partnership continuing.
Congratulations to LCGC North America for 25 years of providing insightful resources to the scientific instrumentation community. As the leader in laboratory gas generation, Parker has relied upon LCGC as an important business partner in reaching our users. We see that partnership continuing.
Laboratories around the world have a constant need for reliable sources of high-purity gas to operate analytical instrumentation. ParkerBalston on-site, gas generation systems satisfy these needs while offering customers a safer, cost-effective alternative to traditional methods of high purity gas delivery. When educating the global marketplace about a "better way" technology such as gas generators - informative, credible resources are an important vehicle for customers to reference and learn from. LCGC has provided laboratory instrument users with objective articles and case studies informing customers with how gas generator technologies work and how they can simply make laboratories safer, more efficient places to conduct their research.
In my travels, I have never met an analytical chemist or lab manager who was enjoying the ritual of changing gas cylinders. In turn, ParkerBalston offers the user the ability to shift a paradigm and eliminate these undesirable tasks. Parker Analytical Gas Generators are continuously improving laboratory efficiencies and safety while optimizing accuracy.
ParkerBalston is one of the best-known international brands for gas generators. We offer our customers the broadest array of analytical gas generator technologies available through internal product development programs and acquisition. Recent advances in proton exchange membrane technology for producing hydrogen gas and hollow-fiber membrane technology for producing nitrogen gas, differentiate Parker as the global leader in gas generation for analytical instrumentation. Investment in product innovation will continue to be a focus area.
Our success can also be attributed to our relationships with key global channel partners. Strategic alliances with leading analytical instrument manufacturers, gas companies, and laboratory distributors have allowed us to reach the global marketplace and develop a closer relationship with our customers.
As we continue into the next 25 years, customers will be looking to Parker for innovation in safety and efficiency. As advances in instrumentation evolve, so will the demand for reliable sources of high-purity, analytical gas. We will continue to make investments to provide our customers with innovative solutions and advances in on-site gas generation. LCGC will be an important business partner for us in this effort.
Scott Feenan
Division Sales & Marketing Manager
Parker Hannifin Corporation
Haverhill, Massachusetts
Determining Neurotransmitters in Spinal Cords with UHPLC
February 18th 2025Researchers at Jilin University (Changchun, China) developed a highly sensitive, rapid, and accurate method for analyzing neurotransmitters (NTs) in rat spinal cord tissue. Ultra-high performance liquid chromatography-triple quadrupole tandem mass spectrometry (UHPLC-QqQ-MS/MS) in conjunction with ultra-ionic liquid dispersive liquid-liquid microextraction (UA-MIL-DLLME) were used to extract NTs for analysis.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Revolutionizing LC-MS with Next-Gen Separation for Cyclic Peptide Analysis
February 17th 2025Cyclic peptides, known for their stability and high specificity, are promising therapeutic agents in the fight against cancer, infections, and autoimmune diseases. However, developing effective cyclic peptides presents numerous challenges, including poor pharmacokinetics, efficacy, and toxicity. Traditional methods like liquid chromatography tandem-mass spectrometry (LC-MS/MS) often struggle with resolving isomeric linear peptide metabolites, posing significant risks in safety, efficacy, and regulatory approval. In this paper, Komal Kedia, PhD, will share how she leveraged MOBIE’s high-resolution ion mobility-mass spectrometry (IM-MS) system to achieve a 72% reduction in run times, 200% greater resolving power, and enhanced accuracy in identifying “soft spots” prone to enzymatic degradation.